Secondary prevention Myocardial infarction
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00335 | Atenolol | A synthetic beta-1 selective blocker used in the management of hypertension and chronic angina, and to reduce mortality in known or suspected myocardial infarction in hemodynamically stable patients. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00335 | Atenolol | Beta-1 adrenergic receptor | target |
| DB00335 | Atenolol | Beta-2 adrenergic receptor | target |
| DB00335 | Atenolol | Cytochrome P450 2D6 | enzyme |
| DB00335 | Atenolol | Bile salt export pump | transporter |
| DB00335 | Atenolol | Serum albumin | carrier |
| Drug | Drug Name | Phase | Status | Count |
|---|